Koninklijke Philips N.V. (ADR)
General ticker "PHG" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $24.2B (TTM average)
Koninklijke Philips N.V. (ADR) follows the US Stock Market performance with the rate: 58.0%.
Estimated limits based on current volatility of 2.9%: low 26.94$, high 28.54$
Factors to consider:
- Company pays dividends (annually): last record date 2025-05-13, amount 0.89$ (Y3.34%)
- Total employees count: 234000 as of 1998
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [19.88$, 32.79$]
- 2025-12-31 to 2026-12-31 estimated range: [19.00$, 31.74$]
Financial Metrics affecting the PHG estimates:
- Positive: with PPE of 17.0 at the end of fiscal year the price was neutral
- Positive: -3.60 < Operating profit margin, % of 2.94
- Negative: negative Industry operating cash flow (median)
- Positive: Inventory ratio change, % of -0.79 <= -0.75
- Negative: Industry earnings per price (median), % of -3.67 <= 0
- Negative: negative Industry operating income (median)
- Positive: Industry inventory ratio change (median), % of -1.44 <= -0.15
- Positive: 6.82 < Operating cash flow per share per price, % of 7.48
- Negative: 0.79 < Interest expense per share per price, % of 1.49
- Positive: -4.48 < Investing cash flow per share per price, % of -2.80
Short-term PHG quotes
Long-term PHG plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | €17,827.00MM | €18,169.00MM | €18,021.00MM |
| Operating Expenses | €19,356.00MM | €18,284.00MM | €17,492.00MM |
| Operating Income | €-1,529.00MM | €-115.00MM | €529.00MM |
| Non-Operating Income | €-202.00MM | €-412.00MM | €-406.00MM |
| Interest Expense | €244.00MM | €306.00MM | €337.00MM |
| R&D Expense | €2,091.00MM | €1,890.00MM | €1,747.00MM |
| Income(Loss) | €-1,731.00MM | €-527.00MM | €123.00MM |
| Taxes | €-113.00MM | €-73.00MM | €963.00MM |
| Profit(Loss)* | €-1,608.00MM | €-466.00MM | €-702.00MM |
| Stockholders Equity | €13,249.00MM | €12,028.00MM | €12,006.00MM |
| Inventory | €4,049.00MM | €3,491.00MM | €3,198.00MM |
| Assets | €30,688.00MM | €29,406.00MM | €28,976.00MM |
| Operating Cash Flow | €-181.82MM | €2,309.26MM | €1,697.17MM |
| Capital expenditure | €466.63MM | €371.90MM | €342.90MM |
| Investing Cash Flow | €-1,575.41MM | €-553.53MM | €-633.87MM |
| Financing Cash Flow | €525.49MM | €-916.79MM | €-536.52MM |
| Earnings Per Share** | €-1.69 | €-0.49 | €-0.75 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.